Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    hero_1.jpeg
    The most trusted distributor of COAs

    700+ exclusive COA distributions on behalf of their copyright owners

    hero_2.jpeg
    PROQOLID™: the largest COA database

    7,000+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    hero_3.jpeg
    About ePROVIDE™

    Online access to all our services and COA databases

    hero_2_2.jpeg
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    hero_3_1.jpeg
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    hero_4_2.jpeg
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    hero_5_1.jpeg
    News
    Hero_5_2.jpeg
    Conferences
    Hero_5_3.jpeg
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments(COAs).

    Read More
    hero_6_1.jpeg
    Team

    A global team of multi-disciplinary experts

    hero_6_2.jpeg
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. Resources
  3. Blog
  4. PROs: A Critical Component in the Development of Patient-Centered Treatments

Patient-Reported Outcomes (PROs): A Critical Component in the Development of Patient-Centered Treatments

  • 08 August 2024

In the ever-evolving landscape of healthcare and clinical research, patient-centricity has become increasingly paramount. Patient Reported Outcomes (PROs) are at the heart of this paradigm shift. 
Patient Reported Outcomes are health outcomes that come directly from patients, without interpretation by clinicians or any other third party. These can include subjective reports on symptoms, quality of life, functional status, and treatment satisfaction. PROs provide a unique window into the patient experience, one that objective clinical outcome measures alone cannot capture.

A Shift Towards Patient-Centricity

Healthcare has traditionally relied heavily on outcomes measured by clinicians and biomarkers to assess novel treatments. While these are undoubtedly important, they often fail to capture the full picture of a patient's experience with a condition or its treatment. Take for example a new treatment that may control the shaking and stiffness for patients suffering from Parkinson’s disease. However, if the treatment causes tremendous drowsiness to the point where patients may not be alert enough to interact with their family, is that considered a success?  The move towards patient-centricity acknowledges that patients are experts in their own experiences and that their perspectives are invaluable in developing effective treatments.

There are several reasons why PROs are considered critical inputs in developing true patient-centered treatments:

  1. Capturing the Patient Experience: PROs allow us to understand aspects of health that are known only to patients. For instance, pain levels, fatigue, or the impact of a condition on daily life are subjective experiences that can't be fully measured by external observation. By incorporating PROs, researchers ensure that treatments address what truly matter to patients
  2. Improving Treatment Efficacy: When the broader picture of patient experience is better understood, researchers can develop more effective treatments. PROs can reveal side effects or quality of life impacts that may not be readily apparent through traditional clinical outcome measures. This can guide modifications to treatments, making sure they are more tolerable and effective from the patient’s perspective
  3. Facilitating Comparative Effectiveness Research: PROs allow for more comprehensive comparisons between different treatment modalities. By including patient-centered metrics, researchers can evaluate treatments not just based on their clinical efficacy, but on their overall impact on patients' lives
  4. Supporting Regulatory Decisions: Regulatory bodies like the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [RS1] are increasingly recognizing the value of PROs in evaluating new treatments. PRO data can provide compelling evidence of a treatment's benefits in terms that are directly relevant to patients, potentially influencing approval decisions
  5. Identifying Unmet Needs: With the use of PROs, researchers can uncover aspects of diseases or treatments that may be overlooked when relying solely on traditional clinical measures. Such insights can help drive innovations that address previously unrecognized patient needs
  6. Better Patient Engagement and Satisfaction: Incorporating the use of PROs in clinical trials and treatment assessment allows patients to have active participation in their healthcare. This engagement can lead to increased satisfaction with care, better adherence to treatment regimens, and ultimately, improved health outcomes
  7. Assisting Clinical Decision Making: PROs can help inform shared decision-making between patients and healthcare providers. When clinicians have access to PRO data, they can make more informed decisions that align with patient preferences, values and experiences
  8. Increasing the Value of Healthcare: By recognizing what matters most for the patients and enabling patients and healthcare providers to better communicate about treatment goals and expectations. At a higher level, provisions can be made to address gaps in delivery system, such as anticipation of complementary services or changes in care settings such as counseling before surgery, or at-home rehabilitation.   

Challenges and Considerations When Implementing PROs

While the benefits of PROs are clear, their implementation is not without challenges. Ensuring the validity and reliability of PRO measures, standardizing data collection, integrating PRO data with other clinical information and appropriate interpretation of findings are ongoing areas of development in the field. Particularly, the interpretation of PRO data requires careful consideration due to cultural differences, individual patient perspectives, and the differing contexts of data collection. As reliance on PROs is increasing across multiple sectors of medical research and clinical care, robust methodologies for their collection and analysis should be established.

In summary, PROs bridge the gap between clinical efficacy and real-world effectiveness, ensuring that treatments not only work from a medical standpoint but also meaningfully improve patients' lives. As researchers continue to advance treatment development, PROs will undoubtedly play an increasingly central role in shaping a healthcare system that truly puts patients first. 

By enabling, encouraging and supporting the use of PROs, Mapi Research Trust is proud to help foster a patient-centered approach to treatment development, and build a future where treatments are not only clinically effective, but also profoundly improve in the lives of those they aim to help.

In this section
In this section
  • Blog
  • Publications
    • PROQOLID
    • PROLABELS
    • Literature Review
    • Intellectual Property, copyright issues, and distribution of Patient-Centered Outcomes
    • Translation & Linguistic validation
    • Therapeutic areas
      • Digestive health, gastroenterology, metabolism
      • Endocrinology
      • General
      • Gynecology
      • Hematology
      • Infectious disease, immunology, vaccines
      • Ophthalmology
      • Pain
      • Psychiatry-psychology
      • Rare Diseases
      • Respiratory
      • Rheumatology–musculoskeletal disorders
      • Urology
    • Cochrane HRQoL Methods Group
    • Development projects
    • Education
    • ERIQA/PRO harmonization
    • IQOD
  • Useful links
  • Webinar recordings
  • Whitepapers
    • Whitepaper | COAs and copyright
    • The COA licensing process: How to prepare for success
    • Whitepaper | Digitizing COAs: A streamlined approach to approval
Webpage

ePROVIDE™: COA centralized platform

Webpage

PROQOLID™: COA database

Webpage

Clinical Outcome Assessments (COAs)

Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2025 Mapi Research Trust
  • Disclaimer
  • Privacy
  • Site Cookies
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption